Senior insider sale
Chief Commercial Officer at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$3.82M
53.04K shares
What this filing means
MOTTIWALA AZIZ plans to sell 53.04K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $3.82M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/19/2026ACC: 0001959173-26-006221
Officer· Chief Commercial Officer
Since Oct 2020
53.04K
Shares to sell
$3.82M
Approx. market value
53.04K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/19/2026
53.04KTotal acquired53.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/19/2026 | Stock Option Exercise Cash | 53.04K | — |
| Total | 53.04K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
53.04K
Market value
$3.82M
8/19/2026
Total
Units
53.04K
Value
$3.82M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/19/2026 | 53.04K | $3.82M | NASDAQ | Planned |
| Total | 53.04K | $3.82M | ||